Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8418547 | 0.73 | PIK3CD (0.34) | — | |
| SCHEMBL11161329 | 0.73 | — | — | |
| SCHEMBL30695265 | 0.66 | TGM2 (0.34) | TSHR | |
| SCHEMBL6348530 | 0.63 | LMNA (0.36) | TSHR | |
| SCHEMBL9420472 | 0.63 | ALDH1A1 (0.37) | TSHR | |
| SCHEMBL4120737 | 0.63 | TSHR (0.40) | TSHR | |
| SCHEMBL974246 | 0.62 | FGFR4 (0.35) | TSHR | |
| SCHEMBL27917088 | 0.62 | TGM2 (0.38) | TSHR | |
| SCHEMBL23581934 | 0.61 | ALDH1A1 (0.40) | TSHR | |
| SCHEMBL28602531 | 0.61 | TSHR (0.34) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6991781-B2 | Delivery of reactive agents via bi-layer structures for use in shelf-stable products | THE PROCTER & GAMBLE COMPANY (US) | 2006-01-31 | — | — | US | disclosed |
| US-6936264-B2 | Delivery of reactive agents via multiple emulsions for use in shelf stable products | THE PROCTER & GAMBLE COMPANY (US) | 2005-08-30 | — | — | US | disclosed |
| EP-1392221-A2 | DELIVERY OF REACTIVE AGENTS VIA MULTIPLE EMULSIONS FOR USE IN SHELF STABLE PRODUCTS | The Procter & Gamble Company (US) | 2004-03-03 | — | — | EP | disclosed |
| US-20020155080-A1 | Delivery of reactive agents via multiple emulsions for use in shelf stable products | PROCTER & GAMBLE COMPANY, THE | 2002-10-24 | — | — | US | disclosed |
| US-20020131944-A1 | Delivery of reactive agents via bi-layer structures for use in shelf-stable products | PROCTER & GAMBLE COMPANY, THE | 2002-09-19 | — | — | US | disclosed |
| WO-2002069917-A2 | DELIVERY OF REACTIVE AGENTS VIA MULTIPLE EMULSIONS FOR USE IN SHELF STABLE PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2002-09-12 | — | — | WO | disclosed |
| US-4859460-A | REACTING HAIR WITH REDUCING AGENT THEN POLYHALOACETYLATED POLYMER | SOCIETE ANONYME DITE L'OREAL (FR) | 1989-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020131944-A1 | Delivery of reactive agents via bi-layer structures for use in shelf-stable products | TYR, LPO, ABAT | TSHR 2775/4885 |
| US-20020155080-A1 | Delivery of reactive agents via multiple emulsions for use in shelf stable products | POLR1C, IMMT, NACA | TSHR 2592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.